recombinant hepatitis B vaccine (Hansenula polymorpha yeast) (Jiangsu Theravac Bio-Pharmaceutical)

N/A

Report date: 2025/01/26 16:51:24

Base Information

Drug Namerecombinant hepatitis B vaccine (Hansenula polymorpha yeast) (Jiangsu Theravac Bio-Pharmaceutical)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionViral structural proteins modulators
TargetsViral structural proteins
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Theravac Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Theravac Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A